Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT Therapy in Metastatic Colorectal Cancer
NCT01729923Phase 2Terminated
- Sponsor
- University of Washington
- Start
- Mar 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in colorectal cancer (metastatic) (mCRC), sponsored by University of Washington. Started Mar 2013; status: terminated.
02
Drugs
celecoxib oral solution
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01729923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01729923.